Have you read these stories?

Why cutting share of states to fund defence is a bad idea

The shift in the fiscal centre of gravity means that things that constrain states’ finances would worsen the slump.

ranexa

Sep 18, 2019, 03.02 AM IST

SEARCHED FOR:

RANEXA

Glenmark gets final nod from USFDA for angina treatment drug

The product is a generic version of Gilead Sciences Inc's Ranexa extended-release tablets in the same strengths.

Banks, oil and gas majors may lead 15-20% earnings growth this quarter: Mayuresh Joshi

The markets might remain very volatile in shor term, s...

Sell Lupin, target Rs 800: Elara Capital

Sell Lupin at a price target of Rs 800.

ET Prime Distribution
Load More...
x

Other useful Links


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service